1. Is Seprafilm valuable in infant cardiac redo procedures?
- Author
-
Lefort, Bruno, El Arid, Jean-Marc, Bouquiaux, Anne-Lorraine, Soulé, Nathalie, Chantreuil, Julie, Tavernier, Elsa, Chantepie, Alain, and Neville, Paul
- Subjects
- *
HEART abnormalities , *MULTIVARIATE analysis , *BIOMARKERS , *CONGENITAL heart disease , *CARDIOPULMONARY bypass , *THERAPEUTICS - Abstract
Background: Morbidity and mortality are higher for cardiac reoperations than first operation due to the presence of post-operative adhesions. We retrospectively evaluated the efficacy of the bioresorbable membrane Seprafilm® to prevent pericardial adhesions after cardiac surgery in a paediatric congenital heart disease population. Methods: Seventy-one children undergoing reoperations with sternotomy redo and cardiopulmonary bypass for congenital malformations were included. Twenty-nine of these patients were reoperated after previous application of Seprafilm® (treatment group). The duration of dissection, aortic cross clamping and total surgery were recorded. A tenacity score was established for each intervention from the surgeon's description in the operating report. Results: In multivariate analysis, the duration of dissection and the tenacity score were lower in the treatment than control group (p < 0.01), independent of age and interval since preceding surgery. Conclusion: Our results suggest that Seprafilm® is effective in reducing the post-operative adhesions associated with infant cardiac surgery. We recommend the use of Seprafilm® in paediatric cardiac surgery when staged surgical interventions are necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF